New York State Common Retirement Fund Regenxbio Inc. Transaction History

New York State Common Retirement Fund

$75.8 Billion
Q1 2024

A detailed history of New York State Common Retirement Fund transactions in Regenxbio Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 16,300 shares of RGNX stock, worth $177,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,300

Previous 16,300 -0.0%

Holding current value

$177,670

Previous $293,000 17.06%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$12.89 - $20.82 $5,504 - $8,890	-427 Reduced 2.55%	16,300 $293,000
Q3 2023 Nov 07, 2023	BUY	$16.46 - $19.99 $2,106 - $2,558	128 Added 0.77%	16,727 $275,000
Q2 2023 Aug 07, 2023	SELL	$17.23 - $21.71 $129,845 - $163,606	-7,536 Reduced 31.22%	16,599 $332,000
Q1 2023 May 02, 2023	SELL	$18.08 - $24.55 $77,870 - $105,736	-4,307 Reduced 15.14%	24,135 $456,000
Q4 2022 Jan 30, 2023	SELL	$20.4 - $24.73 $306 - $370	-15 Reduced 0.05%	28,442 $645,000

Q3 2022 Nov 08, 2022	BUY	$22.29 - $35.04 $1,136 - $1,787	51 Added 0.18%	28,457 $752,000
Q2 2022 Aug 04, 2022	SELL	$19.35 - $35.04 $890 - $1,611	-46 Reduced 0.16%	28,406 $702,000
Q1 2022 May 05, 2022	SELL	$24.62 - $34.31 $344 - $480	-14 Reduced 0.05%	28,452 $944,000
Q4 2021 Feb 02, 2022	SELL	$30.19 - $40.28 $1,811 - $2,416	-60 Reduced 0.21%	28,466 $931,000
Q3 2021 Nov 02, 2021	SELL	$29.09 - $45.68 $212,124 - $333,098	-7,292 Reduced 20.36%	28,526 $1.2 Million
Q2 2021 Aug 02, 2021	BUY	$32.46 - $40.48 $175,868 - $219,320	5,418 Added 17.82%	35,818 $1.39 Million
Q4 2020 Feb 08, 2021	SELL	$26.52 - $49.35 $60,996 - $113,505	-2,300 Reduced 7.03%	30,400 $1.38 Million
Q2 2020 Aug 07, 2020	BUY	$27.75 - $43.44 $74,925 - $117,288	2,700 Added 9.0%	32,700 $1.2 Million
Q4 2019 Feb 05, 2020	SELL	$34.54 - $44.87 $158,884 - $206,402	-4,600 Reduced 13.29%	30,000 $1.23 Million
Q2 2019 Aug 09, 2019	SELL	$42.0 - $59.29 $232,764 - $328,585	-5,542 Reduced 13.81%	34,600 $1.78 Million
Q1 2019 May 08, 2019	BUY	$40.82 - $62.45 $170,260 - $260,478	4,171 Added 11.6%	40,142 $2.3 Million
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $117,877 - $226,502	-3,014 Reduced 7.73%	35,971 $1.51 Million
Q3 2018 Nov 07, 2018	BUY	$65.0 - $82.15 $467,025 - $590,247	7,185 Added 22.59%	38,985 $2.94 Million
Q2 2018 Aug 10, 2018	BUY	$27.2 - $74.35 $51,680 - $141,265	1,900 Added 6.35%	31,800 $2.28 Million
Q2 2017 Aug 11, 2017	BUY	N/A	29,900	29,900 $591,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $471M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Regenxbio Inc. Transaction History